Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001721526-17-000001
Filing Date
2017-11-03
Accepted
2017-11-03 15:49:12
Documents
1
Period of Report
2017-10-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 14711
  Complete submission text file 0001721526-17-000001.txt   16124
Mailing Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549
Business Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549 (914) 244-1777
Immudyne, Inc. (Issuer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 50 SPRING MEADOW ROAD MOUNT KISCO NY 10549
Business Address
McLaughlin Mark (Reporting) CIK: 0001721526 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55857 | Film No.: 171176328